8-K filed February 2, 2026, 6:59 PM ET ticker KRAQ CIK 0002082119

other material confidence high sentiment neutral materiality 0.70

KRAKacquisition Corp closes upsized $345M IPO; 34.5M units at $10 each

KRAKacquisition Corp

Gross proceeds $345M from 34.5M units (full overallotment); each unit = 1 Class A share + 1/4 warrant exercisable at $11.50.
Sponsor purchased 2.25M private placement warrants at $1 each, generating $2.25M additional proceeds.
Net proceeds deposited in trust account; Company has 24 months to complete initial business combination or redeem shares.
Board expanded to 16; three former KRAK directors appointed: Michael Van de Ven, Barbara Smith, Derek Kerr.
Company has not selected any business combination target and has not engaged in substantive discussions.

item 1.01 item 3.02 item 5.02 item 5.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001140361-26-003274
form_type: 8-K
ticker: KRAQ
cik: 0002082119
company_name: KRAKacquisition Corp
filed_at: 2026-02-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.210061+00:00
generated_at: 2026-05-16T05:47:09.379634+00:00
sec_items: ["1.01", "3.02", "5.02", "5.03", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001140361-26-003274
json_url: https://secwatch.observer/filing/0001140361-26-003274.json
markdown_url: https://secwatch.observer/filing/0001140361-26-003274.md
text_url: https://secwatch.observer/filing/0001140361-26-003274.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2082119/000114036126003274/0001140361-26-003274-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2082119/000114036126003274/ny20054630x13_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

7c611e6afdc5b99aa661b42e1f004588314ba222

KRAKacquisition Corp: Adopted Second Amended and Restated Memorandum and Articles of Association (effective 2026-01-27).

On January 27, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

0e1bdfc8c79473ecae0d3d22db94a614adbed2f9

KRAKacquisition Corp entered into Private Placement Warrants Purchase Agreement with NCTK Sponsor LLC (effective 2026-01-27).

a Private Placement Warrants Purchase Agreement, dated January 27, 2026, between the Company and NCTK Sponsor LLC (the “ Sponsor ”), pursuant to which the Sponsor purchased 2,250,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, at a price of $1.00 per warrant

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

34d76251aa0bc32bf9209848aefa6452d0fca3f3

KRAKacquisition Corp entered into Registration Rights Agreement with NCTK Sponsor LLC and other Holders (effective 2026-01-27).

a Registration Rights Agreement, dated January 27, 2026, between the Company, the Sponsor and the other Holders (as defined therein) signatory thereto

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

5510e8d1b70445488f87730dbca98f54b661bfd4

KRAKacquisition Corp entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-01-28).

a Warrant Agreement, dated January 28, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “ Warrant Agreement ”)

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

a3d0dc59ee33103bf197749938ee6a83684b508b

KRAKacquisition Corp entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-01-28).

an Investment Management Trust Agreement, dated January 28, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

deb426f78ba862735cf0497f3d95deee2d19848a

KRAKacquisition Corp entered into Underwriting Agreement with Santander US Capital Markets LLC (effective 2026-01-27).

Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement: ● an Underwriting Agreement, dated January 27, 2026, between the Company and Santander US Capital Markets LLC, which contains customary

SEC 8-K Item 1.01/1.02 confidence 0.95 SEC evidence

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 27, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 27, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 27, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

CLRB

Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data

Cellectar Biosciences, Inc. May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 8.01, 9.01 same event type: other_material similar materiality

This filing

a Private Placement Warrants Purchase Agreement, dated January 27, 2026, between the Company and NCTK Sponsor LLC (the “ Sponsor ”), pursuant to which the Sponsor purchased 2,250,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, at a price of $1.00 per warrant

Comparable filing

pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 9.01 same event type: other_material similar materiality

This filing

On January 27, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

ADT

Apollo sells all 102M ADT shares; ADT repurchases 29.1M shares in $1.5B plan

ADT Inc. May 8, 2026, 7:59 PM ET other_material Items 5.02, 5.03, 8.01, 9.01

same fact type: governance_change same SEC item: 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 27, 2026, the Company adopted its Second Amended and Restated Memorandum and Articles of Association.

Comparable filing

On May 8, 2026, the Board approved an amendment and restatement of the Company’s Amended and Restated Bylaws, dated as of September 15, 2023 (as amended, the “ Bylaws ”), to remove references related to Apollo and the Amended and Restated Stockholders Agreement, dated December 14, 2018, between the Company, Prime Security Services TopCo Parent, L.P., and the Co-Investors.

Filing page SEC filing

TPST

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73

Tempest Therapeutics, Inc. June 1, 2026, 7:13 PM ET other_material Items 1.01, 3.02, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

This filing

a Private Placement Warrants Purchase Agreement, dated January 27, 2026, between the Company and NCTK Sponsor LLC (the “ Sponsor ”), pursuant to which the Sponsor purchased 2,250,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, at a price of $1.00 per warrant

Comparable filing

On May 28, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the “ Company ”), entered into a warrant exercise and inducement offer letter agreement (the “ Inducement Letter ”) with a holder of certain existing warrants to purchase shares of the Company’s common stock

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

This filing

a Private Placement Warrants Purchase Agreement, dated January 27, 2026, between the Company and NCTK Sponsor LLC (the “ Sponsor ”), pursuant to which the Sponsor purchased 2,250,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, at a price of $1.00 per warrant

Comparable filing

On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).

Filing page SEC filing

Source: SEC EDGAR

accession 0001140361-26-003274

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.